Cargando…

The Role of Secondary Surgery in Recurrent Ovarian Cancer

Despite optimal treatment (complete cytoreduction and adjuvant chemotherapy), 5-year survival for advanced ovarian cancer is approximately 30% and most patients succumb to their disease. Cytoreductive surgery is accepted as a major treatment of primary ovarian cancer but its role in recurrent diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorusso, D., Mancini, M., Di Rocco, R., Fontanelli, R., Raspagliesi, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420128/
https://www.ncbi.nlm.nih.gov/pubmed/22919475
http://dx.doi.org/10.1155/2012/613980
Descripción
Sumario:Despite optimal treatment (complete cytoreduction and adjuvant chemotherapy), 5-year survival for advanced ovarian cancer is approximately 30% and most patients succumb to their disease. Cytoreductive surgery is accepted as a major treatment of primary ovarian cancer but its role in recurrent disease is controversial and remains a field of discussion mainly owing to missing data from prospective randomized trials. A critical review of literature evidence on secondary surgery in recurrent ovarian cancer will be described.